anti-EGFR antibody
- Generic Name
- anti-EGFR antibody
A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707-101)
Phase 1
Active, not recruiting
- Conditions
- Metastasis
- Interventions
- First Posted Date
- 2019-07-05
- Last Posted Date
- 2024-10-21
- Lead Sponsor
- Synthorx, Inc, a Sanofi company
- Target Recruit Count
- 250
- Registration Number
- NCT04009681
- Locations
- 🇦🇺
Investigational Site Number-2002, Victoria, Australia
🇦🇺Investigational Site Number-2003, Victoria, Australia
🇨🇱Investigational Site Number- 6001, Santiago, Chile
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath